Neuphoria Therapeutics Inc., a Delaware corporation, has successfully completed the redomiciliation process of Bionomics Limited, an Australian corporation, on December 23, 2024. This transformative ...

Bionomics ( (BNOX) ) has issued an update. Neuphoria Therapeutics Inc. has completed its redomiciliation, transferring ...

Neuphoria Therapeutics shares closed up in their first Nasdaq trading day after Bionomics re-domiciled to the U.S. from Australia and Neuphoria became the ultimate parent company of Bionomics. The ...

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...

Merck & Co. Inc. has turned to Asia for a second time to get into the GLP-1 market. Shanghai-based Hansoh Pharmaceutical Group Co. Ltd. has licensed HS-10535, an investigational preclinical oral small ...

Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company) is pleased to announce that the Supreme Court of New South Wales, ...

The year is ending with an ongoing strong flow of clinical results – and is unlikely to abate in 2026. ... Read More The post ...

Bionomics (BNOX) announced that the Supreme Court of New South Wales, Australia has made orders approving the scheme of arrangement in relation ...

Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company) is pleased to announce that the Supreme Court of New South Wales, Australia (“Court”) has today made orders approving the scheme of arrangement ...

H.C. Wainwright has recently raised Bionomics Ltd – ADR (BNOX) stock to Buy rating, as announced on September 28, 2023, according to Finviz. Earlier, on September 28, 2023, Maxim Group had reiterated ...

ADELAIDE, Australia and CAMBRIDGE, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (“Bionomics” or the “Company”) is pleased to provide the following update on the status of ...